PT  - JOURNAL ARTICLE
AU  - Jessica Williams
AU  - Emma Meadows
AU  - Manrita Singh
TI  - Post–COVID-19 New Normal for Molecular Imaging Departments: A United Kingdom Perspective
AID  - 10.2967/jnmt.120.252635
DP  - 2020 Sep 01
TA  - Journal of Nuclear Medicine Technology
PG  - 227--233
VI  - 48
IP  - 3
4099  - http://tech.snmjournals.org/content/48/3/227.short
4100  - http://tech.snmjournals.org/content/48/3/227.full
SO  - J. Nucl. Med. Technol.2020 Sep 01; 48
AB  - Coronavirus disease 2019 has changed the way the world is navigated and has had a massive impact on health care. Depending on where you are in the world, the guidance on dealing with potential infected patients is varied. With the high risk of a second wave, it is important to learn from initial responses to plan for the future. With proper preparation, it is possible to minimize exposure and risk of contamination to individuals visiting molecular imaging departments. Such precautions will help departments operate at full capacity. From the widespread nature of this pandemic, a global perspective can be useful; what follows is the United Kingdom’s perspective.